S129: Metabolic engineering to increase production of malonyl-CoA derived products

Thursday, August 15, 2013: 8:30 AM
Nautilus 1-2 (Sheraton San Diego)
Tanya Lipscomb, Ashley Trahan, Travis Wolter, Wendy Ribble, Alicia Navetta, Katie Lundeen, Andrew Buhrmann, Carlos Batista, Anna Kurt, Anna Hotwick, Amar Singh, Jordan Krause, Melanie Desessa, Monica Munguia, Michael Louie, Sarah McAfee, Rupal Prabhu, Serena Gold, Ron Evans, Hendrik Meerman, Hans Liao and David Hogsett, OPXBIO, Boulder, CO
As the demand for fuels and chemicals increases, the biological production of products from renewable feedstocks has become a means of supplementing or even replacing a number of traditionally petroleum-based products. This growing field of bio-refining relies upon the use of microorganisms to convert renewable carbon sources into higher value products.   OPXBIO has engineered strains towards the economical production of 3-hydroxypropionic acid (3-HP), which has been widely recognized as a platform bio-product with several valuable market applications.  One such product, the monomer acrylic acid, represents an $8 Billion global opportunity with end-product applications in paints and coatings, textiles, water treatment, and superabsorbent polymers.  A key focus of strain development efforts was towards increasing the cellular pools of malonyl-CoA, the first committed intermediate for the 3-HP production pathway. This engineered micro-organism and bioprocess is capable of producing commercially relevant rates, titers, and yields of 3-HP, which enable the large scale production of biologically derived acrylic acid at production costs competitive with petroleum based sources.